USANA HEALTH SCIENCES, INC. (USNA) Operating Margin
- Operating margin · 12 months: Value -0.12%; Formula and calculation Operating income / revenue. Period ending 2026-07-04..
Operating margin
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -0.12% | Operating income / revenue. Period ending 2026-07-04. $-1.08M ÷ $913.36M × 100 ≈ -0.12% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.08M USD | Operating Income (Loss) |
| Revenue | 913.36M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 206.00M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 334.60M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-04 | $-1.08M | $913.36M | $206.00M | (m) | $334.60M | -0.12% |
| 2026-04-04 | $35.63M | $925.94M | $207.84M | (m) | $334.19M | 3.85% |
| 2026-01-03 | $37.43M | $925.26M | $200.85M | $10.69M | $337.37M | 4.05% |
| 2025-09-27 | $41.82M | $912.67M | $190.00M | (m) | $332.64M | 4.58% |
| 2025-06-28 | $56.20M | $899.22M | $180.44M | (m) | $307.99M | 6.25% |
| 2025-03-29 | $57.32M | $876.24M | $170.59M | (m) | $290.41M | 6.54% |
| 2024-12-28 | $66.32M | $854.50M | $161.21M | $11.57M | $263.27M | 7.76% |
| 2024-09-28 | $82.33M | $861.97M | $164.98M | (m) | $248.58M | 9.55% |
| 2024-06-29 | $84.34M | $875.12M | $168.25M | (m) | $250.59M | 9.64% |
| 2024-03-30 | $90.90M | $900.45M | $171.24M | (m) | $254.36M | 10.09% |
| 2023-12-30 | $93.07M | $921.01M | $176.69M | $11.45M | $256.99M | 10.11% |
| 2023-09-30 | $91.40M | $927.89M | $180.80M | (m) | $259.43M | 9.85% |
| 2023-07-01 | $96.43M | $947.82M | $184.84M | (m) | $262.14M | 10.17% |
| 2023-04-01 | $101.39M | $974.09M | $191.03M | (m) | $260.43M | 10.41% |
| 2022-12-31 | $107.61M | $998.60M | $193.89M | $11.56M | $262.30M | 10.78% |
| 2022-10-01 | $116.57M | $1.04B | $199.98M | (m) | $269.79M | 11.23% |
| 2022-07-02 | $134.71M | $1.08B | $204.13M | (m) | $270.42M | 12.48% |
| 2022-04-02 | $159.06M | $1.15B | $211.63M | (m) | $276.27M | 13.82% |
| 2022-01-01 | $170.19M | $1.19B | $217.90M | $11.11M | $279.11M | 14.34% |
| 2021-10-02 | $191.22M | $1.23B | $224.40M | (m) | $279.69M | 15.55% |
| 2021-07-03 | $195.81M | $1.25B | $230.04M | (m) | $278.70M | 15.62% |
| 2021-04-03 | $181.68M | $1.18B | $220.70M | (m) | $267.34M | 15.45% |
| 2021-01-02 | $176.49M | $1.13B | $209.11M | $10.63M | $261.19M | 15.55% |
| 2020-09-26 | $168.52M | $1.10B | $197.38M | (m) | $257.07M | 15.38% |
| 2020-06-27 | $158.63M | $1.06B | $188.84M | (m) | $257.68M | 15.00% |
| 2020-03-28 | $150.20M | $1.05B | $187.66M | (m) | $263.65M | 14.24% |
| 2019-12-28 | $146.19M | $1.06B | $187.50M | $10.26M | $267.73M | 13.78% |
| 2019-09-28 | $150.19M | $1.09B | $189.68M | (m) | $270.95M | 13.80% |
| 2019-06-29 | $160.24M | $1.12B | $193.74M | (m) | $273.80M | 14.25% |
| 2019-03-30 | $180.23M | $1.17B | $197.24M | (m) | $274.48M | 15.40% |
| 2018-12-29 | $188.35M | $1.19B | $200.71M | $10.24M | $275.06M | 15.84% |
| 2018-09-29 | $175.68M | (m) | (m) | (m) | $278.22M | (m) |
| 2018-06-30 | $161.52M | (m) | (m) | (m) | $276.37M | (m) |
| 2018-03-31 | $142.75M | (m) | (m) | (m) | $271.23M | (m) |
| 2017-12-30 | $132.50M | (m) | (m) | $8.95M | $265.09M | (m) |
| 2017-09-30 | $128.45M | (m) | (m) | (m) | $250.86M | (m) |
| 2017-07-01 | $132.92M | (m) | (m) | (m) | $244.19M | (m) |
| 2017-04-01 | $138.00M | (m) | (m) | (m) | $241.56M | (m) |
| 2016-12-31 | $138.62M | (m) | (m) | $8.84M | $234.19M | (m) |
| 2016-10-01 | $141.92M | (m) | (m) | (m) | $230.84M | (m) |
| 2016-07-02 | $144.06M | (m) | (m) | (m) | $223.01M | (m) |
| 2016-04-02 | $145.38M | (m) | (m) | (m) | $215.75M | (m) |
| 2016-01-02 | $141.66M | (m) | (m) | $6.42M | $209.00M | (m) |
| 2015-10-03 | $139.16M | (m) | (m) | (m) | $206.39M | (m) |
| 2015-07-04 | $130.45M | (m) | (m) | (m) | $199.13M | (m) |
| 2015-04-04 | $120.77M | (m) | (m) | (m) | $189.83M | (m) |
| 2015-01-03 | $116.10M | (m) | (m) | $5.13M | $184.53M | (m) |
| 2014-09-27 | $112.47M | (m) | (m) | (m) | $172.96M | (m) |
| 2014-06-28 | $107.91M | (m) | (m) | (m) | $168.61M | (m) |
| 2014-03-29 | $115.27M | (m) | (m) | (m) | $168.38M | (m) |
| 2013-12-28 | $116.71M | (m) | (m) | $5.08M | $166.21M | (m) |
| 2013-09-28 | $115.79M | (m) | (m) | (m) | $165.61M | (m) |
| 2013-06-29 | $115.18M | (m) | (m) | (m) | $164.81M | (m) |
| 2013-03-30 | $103.88M | (m) | (m) | (m) | $158.61M | (m) |
| 2012-12-29 | $98.18M | (m) | (m) | $4.66M | $154.24M | (m) |
| 2012-09-29 | $90.20M | (m) | (m) | (m) | $149.18M | (m) |
| 2012-06-30 | $84.89M | (m) | (m) | (m) | $142.20M | (m) |
| 2012-03-31 | $80.89M | (m) | (m) | (m) | $139.22M | (m) |
| 2011-12-31 | $77.26M | (m) | (m) | (m) | $137.06M | (m) |
| 2011-10-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-01 | $68.22M | (m) | (m) | (m) | $120.76M | (m) |
| 2010-10-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-02 | $50.79M | (m) | (m) | (m) | $99.98M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |